Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2401739
Max Phase: Preclinical
Molecular Formula: C27H24ClFN2
Molecular Weight: 395.50
Molecule Type: Small molecule
Associated Items:
ID: ALA2401739
Max Phase: Preclinical
Molecular Formula: C27H24ClFN2
Molecular Weight: 395.50
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Fc1ccc(C[n+]2ccc3c4ccccc4n(CCCc4ccccc4)c3c2)cc1.[Cl-]
Standard InChI: InChI=1S/C27H24FN2.ClH/c28-23-14-12-22(13-15-23)19-29-18-16-25-24-10-4-5-11-26(24)30(27(25)20-29)17-6-9-21-7-2-1-3-8-21;/h1-5,7-8,10-16,18,20H,6,9,17,19H2;1H/q+1;/p-1
Standard InChI Key: SSFOOZRUHRHSFT-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 395.50 | Molecular Weight (Monoisotopic): 395.1918 | AlogP: 5.90 | #Rotatable Bonds: 6 |
Polar Surface Area: 8.81 | Molecular Species: NEUTRAL | HBA: 1 | HBD: 0 |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 2.48 | CX LogD: 2.48 |
Aromatic Rings: 5 | Heavy Atoms: 30 | QED Weighted: 0.32 | Np Likeness Score: -0.68 |
1. Zhang G, Cao R, Guo L, Ma Q, Fan W, Chen X, Li J, Shao G, Qiu L, Ren Z.. (2013) Synthesis and structure--activity relationships of N²-alkylated quaternary β-carbolines as novel antitumor agents., 65 [PMID:23688697] [10.1016/j.ejmech.2013.04.031] |
Source(1):